A series of amide derivatives of natural glycopeptide A-40,926 (A), its 6B-methyl ester (MA) and 6B-decarboxy-6B-hydroxymethyl derivative (RA) were prepared with the aim of obtaining activity against glycopeptide-resistant enterococci. These compounds are structurally related to a class of amides of 34-de(acetylglucosaminyl)-34-deoxy teicoplanin which showed interesting activity against strains of Enterococcus faecalis and E. faecium highly resistant to both vancomycin and teicoplanin. Among them, RA-amides MDL63,246 and MDL63,042 were the most active derivatives against several Gram-positive bacteria, including VanB and VanC enterococci, and were moderately active (MIC range 0.5~64/ig/ml) against strains of Enterococcus for which vancomycin and teicoplanin MICswere > 128^g/ml. The chemical rationale and the synthesis of these newseries of glycopeptide derivatives are described. Preliminary in vitro data are reported and structure-activity relationships are discussed.
In the last few years an increase in serious infections caused by enterococci has been observed in hospitalized patients. Clinical isolates of enterococci are intrinsically resistant to manyclasses of antibacterial drugs, and infections often require treatment with a combination of agents to which they are moderately susceptible. The recent appearance of vancomycin-resistant enterococci poses a serious threat for the near future, particularly because high-level resistance is often associated with genetic elements which can spread from one bacterial strain to another. The emerging resistance in enterococci1} is a current challenge for glycopeptides of the dalbaheptide2) family since teicoplanin ( Amongthe teicoplanin derivatives, some basic amides (Fig. 1)4) of the 34-de(acetylglucosaminyl)-34-deoxy pseudoaglycone had interesting in vitro activity against strains of Enterococcus faecalis and E. faecium highly resistant to both vancomycin and teicoplanin. These acetylglucosamine-less derivatives also differ from corresponding teicoplanin amides in the absence of the oxygen at C-34. The benzylic hydroxyl group on amino acid 6 is always present in natural dalbaheptides and seems to contribute to stabilization of the macrocyclic ring formed by amino acid fragments 5, 6 and 7 in the natural conformation in which the 5,6-peptide bond is "cisoid".
The teicoplanin-like antibiotic A-40,926 (Fig. 3 ),5>6) was considered to be a more suitable starting material than teicoplanin for the preparation of derivatives containing the original 34-hydroxyl group, as it lacks the 34-acetylglucosamine. It has a mannose and a single 7V-acylamino sugar in the same positions as teicoplanin.
To further increase the similarities between these with 3,3-dimethylamino-l-propylamine were also prepared. Finally, the sugar-free compound DMGA-A-1 (the aglycone of MDL63,246)^was synthesized to establish the role of the 7V-acylglucosamine on the activity of these compoundsagainst VanAenterococci.
Chemistry The reduction of the 7V-acylglucuronic acid of A to obtain the TV-acylglucosaminyl derivative RAwas carried out via the mono-methyl ester MAintermediate, according to the procedure (Method A) outlined in Scheme la.
The selective esterification of the sugar-carboxyl group of A was performed in methanolic solution at room temperature in the presence of a catalytic amount of H2SO4. The TV-terminal methylamino group of the resulting ester (MA)was suitably protected as tert-buty\ (BOC) carbamate to prevent the possible reductivehydrolysis of the 2,3-amide bond7) with NaBH4. Reduction of the sugar-methyl ester of the 7V15-BOCprotected MA(BOC-MA)to alcohol was obtained upon treatment with an excess of NaBH4in a H2O-BuOH (2 : 1) mixture at room temperature, yielding the BOCderivative (BOC-RA) of RA. The final deprotection step was performed under controlled acidic conditions, in trifiuoroacetie acid (TFA) at 0°C.t2 The 7V63-carboxamide derivatives (MA-A-1~5) of MAand (RA-A-1-5) of RA (Fig. 3 , Table 1 ) were prepared by condensation of the C-38-carboxyl group of MAand RA, respectively, with selected amines in dimethylsulfoxide (DMSO)at room temperature in the presence of benzotriazolyloxy-^rw-pyrrolidinophosphonium-hexafluoro-phosphate (PyBOP), as the condensing agent (Scheme 2a). The amides (A-A-l~3) of A were obtained by saponification of the sugar-methyl ester of the corresponding MA-amideswith I n NaOHat room temperature in a THF -H2O (6 : 1) mixture (Scheme 2b). Selective demannosylation ofA or MA, to give DMA or DMMA (Fig. 4, Table 2 ) was achieved under acidic conditions (37% HC1 in DMSO,at 55~60°C for 15 n DMGA-A-1is the aglycone moiety commonto RA-A-1, A-A-l and MA-A-1 (Fig. 3) . t2 In contrast to the acylglucuronic moiety and its methyl ester present in A and MA,respectively, which are stable under relatively strong acidic conditions, the hemiacetalic bond of the acylglucosamine of RAis susceptible to hydrolysis by TFAeven at room temperature. The instability of this sugar in RAis comparable to that of the acylglucosamine in teicoplanine antibiotics. From the corresponding MA-amide. (Fig. 4) . densation of the 63-COOHof DMMA with the 3,3-dimethylamino-1 -propylamine was carried out (Scheme 2c) as described above in the synthesis of MA-amides.
Reduction of the sugar-methyl ester of the resulting DMMA-A-1with NaBH4 under the usual conditions required well defined reaction conditions to minimize or prevent the formation of by-products (PyMA-and PyRA-amides) due to addition of the Jns-pyrrolidinophosphonium moiety to the phenolic oxygen of aromatic ring 3 (Fig. 5 ). This side reaction, which is favored by basic conditions and by an excess of PyBOP,is due to the relatively strong acidity (PKMCS9.2) of the phenolic Small samples ofPyMA-A-1 and PyRA-A-1 (Table.3) were properly synthesized from MAand RA, respectively, using an excess of PyBOPand dimethylaminopropylamine, while PyA-A-1 was then obtained upon treatment ofPyMA-A-1with 1 n NaOHunder the usual conditions (THF-H2O 6 : 1, room temperature). All derivatives described here are mixtures of four strictly related components, namely factors Bo ( > 70%),t3
and A, Ar and Bx (together, <25%), which differ only in the structure of the aliphatic chain of the 7V-acyl sugar on amino acid 4, plus an additional component, DMBO (<5%),t4 which differs from Bo in the absence of the mannoseon aromatic ring 7. The structures of factors Bo, A, Ax and Bx ( 
Structure Elucidation
The structures of these products were determined by XHNMR spectroscopy and, in some cases, confirmed by FABMSspectrometry and acid-base titration. The IR1"6 and UV1"7 spectra of this series of compounds were in accordance with the structures reported.
NMRSpectroscopy of RA-A-1
The structure of RA-A-1 (Fig. 2) t8 was particularly investigated and confirmed by extensive NMRstudies.
The proton resonances have been assigned by homonuclear proton correlation spectroscopy using DQF-COSY,8) TOCSY,9) ROESY10) and NOESYn) experiments. A complete assignment of all carbon resonances was achieved by HMQC12)and HMBC13)spectra.
Proton chemical shifts: The TOCSYand COSYspectra reveal the presence of 7 amide protons belonging to the spin systems of 5 AXsystems (w3, w4, w5, w6, w7), 1 AXYY' system (w2) and 1 AXX'YY' system (WNN). To distinguish between the 5 AXspin systems (w6/x6 appears as an AXsystem due to the weak coupling between x6 and z6) a sequential assignment using a ROESYor a NOESY experiment was necessary.
t3 Expressed as percentage of the areas of peaks (HPLC). t4 Demannosyl (DM) derivatives are mixtures of four components: Bo (>75%), and A, Al and B1 (<25%). t5 Dealing with mixtures of five (four) components, HPLCanalysis of final products was needed to assess the homogeneous composition of all derivatives in the five componentsand to check the absence of impurities or by-products.
t6 The IR spectra were useful to confirm the presence of the methyl ester function (vco, 1740cm"1) in MA-, DMA-and
t7 The UVspectra of these derivatives are characterized by an absorption maximum at 281 nm. t8 The nomenclature of protons is that generally adopted for teicoplanin3) and other dalbaheptides.
The starting point has been the amide proton WNN on the carboxyl terminus which was easily identified by its unique spin system. Someproblems which occurred due to signal overlapping (x5/x7, w3/w4) were overcome by using additional cross relaxations between the amide protons and protons in the side chains (for example w7/z6 and w5/4f). This is also true for the connectivity between residue 3 and 2; the cross peak between w3 and x2 is very weakbut w3experiences a strong cross relaxation toz2'.
In the Ha region of the ROESYand NOESYspectrum of RA-A-1two very strong cross peaks were obtained both including x6. One of them is due to the correlation with z6 which could not be assigned by scalar coupling. The second peak corresponds to cross relaxation either with x5 or x7 which have identical chemical shift values. However, in the spectrum of the aglycone of A-40,92614) these two protons have different chemical shifts and therefore the ROEcan be attributed unambiguously to x5 indicating a cis-bond between residue 5 and 6 which is characteristic for all glycopeptides of this family (Fig.   6 ).
The TOCSY and COSYspectra were also used for the assignment of the 7 aromatic spin systems. The protons are either correlated with strong coupling constants (in the case of vicinal protons) or relatively weak coupling constants (l~2Hz for long range correlations). All protons which belong to the same ring are connected via scalar coupling in the TOCSY spectrum. In this way it was possible to determine one 1,4-disubstitued (ring 2), coupling constants are normally in the order of 1~2Hz and therefore not detectable in the HMBC spectrum.
However, if the carbon is carrying an electronegative group (OH, OR, Cl) the 2-J(C,H) becomes 3-4Hz and can be observed.15) In DMSO,RA-A-1 exists in two unequally populated conformations which are in slow exchange on the NMR time scale and give rise to two sets of signals in the NMR spectrum. A similar behaviour has been previously described for the structurally related glycopeptide teicoplanin. 16) As shown in Fig. 7 , the ratio of the two conformers is strongly temperature dependant. The portion of the minor conformation increases from 12% at room temperature to 23% at 70°C. The two conformations do not exchange fast enough, even at 70°C, to observe exchange NOEsin the ROESYor the NOESY spectra. These exchange NOEsare usually used to assign easily the resonances of a less populated conformation when other problems arise due to weak signal intensities and/or signal overlapping. In the case of RA-A-1, the assignment of the minor conformation must be carried out independently from the attribution of the major one. To obtain a better signal to noise ratio a TOCSY and a HMQC experiment were performed at 70°C, a temperature at which the portion of the minor conformation is significantly increased (Fig. 8 ). Using these data in combination with the spectra recorded at 30°C it was possible to assign all protons of the peptide core and the anomeric sugar protons. Table 4 gives the proton and carbon chemical shifts of the minor conformation at 30°C in comparison with the corresponding values of the major one. It can be seen that most of the resonances differ significantly indicating a conformational change of the overall structure of the peptide ring.
One of the structural characteristics of this family of glycopeptides is the presence of a cis peptide bond between residues 5 and 6 which is reflected by a very intense NOEbetween the two Ha-protons (x5 and x6).
In the case of the minor conformation such a NOEis not observed which suggests a trans configuration between these residues. The relative rigidity of the peptide core could be the origin of a high energy barrier between the two conformers and therefore be responsible for the slow exchange.
The existance of two different configurations between residue 5 and 6 is supported by the fact that the most striking changes in proton and carbon chemical shifts occur in this region. This is true for the backbone as well as for the side chains (see aromatic protons of ring 5 and AUG. 1995 Table 4 . Chemical Shifts (8, ppm) of the XH and 13C NMR spectra of RA-A-1 (Fig. 2 A commonfeature of the amide derivatives, compared with corresponding unmodified compounds, is the down field shift of the z6 signal by~0.2ppm which is in accordance with formation of the amide.18) The chemical shifts of the basic moieties of the amide chains change according to the ionization status of the molecule. In particular, in the A-l amides the N(CH3)2 signal at 3 2.17ppm (free base) is shifted to 2.50~2.71 ppm when it is' salified with an external anion. The protons of the amide chain in the salified A-2-type derivatives give signals at 3 2.95 and 1.85 ppm. As the free bases, the protons of the amide chain of the A-3 and A-4 compounds resonate at 3 2.81 and 1.73ppm, and at 3 2. 1 1 ppm (7V-methylpiperazine), respectively.
NMRSpectroscopy of Py-Derivatives
The structures of the /ra-pyrrolidinophosphonium (Py) derivatives were determined by *H and 31P NMR spectroscopies.
The presence of the /ra-pyrrolidino moiety was established by TOCSY experiments, while the phosphoryl phosphorus was detected by 31P NMRusing triethylphosphate (TEP) as reference (<5TEP O ppm). The 31P signal was found at 3 25.4ppm. In particular, in the *H NMRspectrum of PyRA-A-1 compared with that of RA-A-1, the down field shift of the x3 (A3 0.06ppm) rhoeae, A-40,926 (A) generally has activity similar to that of teicoplanin, although it tends to be slightly less active than teicoplanin against some staphylococcal isolates14) and shows slight activity (Table 9 and unpublished data) against some VanAenterococci, which are generally more resistant to teicoplanin and always more resistant to vancomycin. The A-amides and some of the MA-amideswere significantly more active than A (Tables 7 and 8 ) against staphylococcal isolates chosen on the basis of their reduced susceptibility to A. These AUG. 1995 amides are also significantly more active than teicoplanin against these isolates (Data not shown); in this respect they behave in a similar manner to certain amides of teicoplanin.18 '20) Most of the RA-amides also had significantly better activity against the selected staphylococci and, in some cases, also had somewhat better activity against streptococci (Table 9 ). However, the most novel feature of the amides, which was particularly evident for some of the MA-and RA-amides, was the moderate activity that they displayed (MIC as low as (Tables 7 and 9 ).
The demannosyl pseudoaglycone (DMA) of A-40,926 was previously reported to have enhanced activity against certain staphylococcal isolates, as compared with A.14) This was confirmed (Tables 7 and 10) , and was also observed for two DMAderivatives (Table 10) . However, the amides of these compounds were even more active against some isolates (Table 10 ) and had activity comparable to those of the amide derivatives discussed above (Tables 7~9) The antibacterial activity of the pyrrolidinyl byproducts PyA-A-1, PyMA-A-1 and PyRA-A-1 (Table   12 ) was similar to that of the corresponding pyrrolidinofree amides against streptococci; however, the pyrrolidinyl compounds were significantly less active against staphylococci. Although they were 4 to 16 fold less active than the parent amides A-A-1, MA-A-1 and RA-A-1 against a glycopeptide-susceptible strain (LI49) of E. faecalis, PyA-A-1, PyMA-A-1 and PyRA-A-1 had comparable or better activity against the glycopeptideresistant strain L562. Most of the derivatives were less active than A-40,926 against N. gonorrhoeae.
Structure-Activity Relationships
In teicoplanin-like antibiotics, activity against highly glycopeptide-resistant (VanA) enterococci correlated with the loss of the 34-acetylglucosamine, as the amide derivatives of A-40,926 and of 34-deacetylglucosaminyl teicoplanin (DAGT)4) were both active against these isolates, while teicoplanin amides were inactive.
The presence or absence of mannose had little or no VanA (19) VanB (7) VanC (5) 0.016-0.13 influence on activity against VanAenterococci, while the presence of the TV-acylglucosamine (RA or DAGT amides), or 7V-acylglucuronic acid (A amides) or its methyl ester (MAamides) was essential for the activity against these bacterial strains.
The removal ofmannose from RA-amide MDL63,246 (RA-A-1) to give DMRA-A-1had no effect on activity against a VanAstrain of Enterococcus faecalis (L562) but the aglycone DMGA-A-1of MDL63,246 had no activity against this strain. As these two compounds had similar activity against a vancomycin-susceptible strain (LI49) of E. faecalis, the 7V-acylglucosamine appears to be specifically required for activity against VanA enterococci, rather than for general anti-enterococcal activity.
C onclusion
The basic amides of A-40,926 (A), its 6B-methyl ester (MA) and 6B-decarboxy-6B-hydroxymethyl derivative (RA) had moderate in vitro activity against isolates of Enterococcus faecalis and E. faecium which are highly resistant to vancomycinand teicoplanin.
Most of these compounds, in particular RA-amides, had excellent activity against all Gram-positive bacteria Aspect station with the UXNMR software from Bruker.
All homonuclear experiments (DQF-COSY, TOCSY and ROESY)were acquired with a spectral width of 1 1 ppm. In all of the experiments, spectra were recorded with 512 increments in tx and 4096 complex data points in t2. For the ROESY 32 transients were averaged for each tx value, for COSYand TOCSY16 transients.
Mixing times of70 or 150ms were used for TOCSYand ROESY/NOESY spectra respectively. For HMQC spectra 512 increments with 2048 complex data points in t2 were collected using a sweep width of llppm in the proton and 165ppm in the carbon dimension. A BIRDpulse21 was applied to suppress magnetization of protons connected to 12C (recovery delay of 200ms).
The HMBCspectra were acquired with a sweep width of llppm in the proton and 165ppm in the carbon dimension. A total of 320 transients were averaged for each of 512 increments in tl5 and 2048 complex points in t2 were recorded. A delay of3.3 mswas used to supress 1-J couplings and 70 ms were taken for the development of long range correlations. After Fourier transformation the strong tx noise was reduced by a meanrowsubtraction using the AURELIAprogram (Bruker).
Phosphorus Determination in P-containing Compounds and in Samples of RA-A-1
The 31P NMR experiments for the phosphorus determination in the Py-derivatives were run using the Powgate (Bruker) microprogram (CPD decoupling, ll.5/iS for 90°pulse) with exponential multiplication (LB=3.3 Hz) prior to Fourier transformation. The 31P
NMRspectra were recorded in DMSO-d6solution at 30°C at 202.46MHz with a Bruker AM500 NMR spectrometer (Aspect 3000 console).
The use ofPyBOPas condensing agent in the synthesis of the amide derivatives produced phosphorus-containno The excellent anti-staphylococcal activity of most of the amide derivatives of A-40,926 was unexpected because analog amides of de-acetylglucosaminyl teicoplanin were generally less active than the corresponding amides of teicoplanin against S. aureus and coagulasenegative staphylococci. To a stirred solution of 1.75g (~1 mol). of MAand lg of NaHCO3 in 50ml of a water-dioxstne (1:1) mixture, a solution of 0.25g (~1.15mmol) of di-tertbutyl dicarbonate (BOC2O) in 5 ml ofdioxane was added dropwise at 5°C within 15 minutes. After 1 hour at room temperature, the reaction mixture was adjusted at pH 4 with 1 n HC1 and 150ml ofH2O was added. The resulting mixture was extracted with BuOH (2x 100ml), the organic layer was washed with 100ml of H2Oand then it was concentrated to a small volume (~25ml) at 40°C under reduced pressure. On adding Et2O (100ml) the precipitated solid (1.6g, BOC-MA) was collected and suspended in 150ml of a H2O-BuOH(2: 1) mixture.
Under vigorous stirring, 1.6g of NaBH4was added portionwise at room temperature over 30minutes. The resulting solution was stirred at room temperature for 1hour, then it was cooled at 5°C and 27ml of glacial AcOHwas added followed by 100 ml ofH2O. Extraction with BuOH (200ml) and evaporation of the organic solvent, at 40°C under reduced pressure, yielded a solid residue (1.5g, BOC-RA) which was dissolved in 15ml ofTFA previously cooled at 0°C. After stirring at 0 -5°C for 25minutes, the resulting solution was poured into 30ml of a Et2O-MeOH (4:1) mixture at 0°C. The precipitated solid was collected, washed several times with Et2O, and then it was dissolved in 100ml of H2O. The resulting solution was adjusted at pH 5.5 with 0.1 n NaOHand loaded on a column of lOOg of silanized silica-gel in a H2O-MeCN(9 : 1) solution. Elution was performed by a linear step gradient from 10 to 50% of A solution of lOmmol ofA, or MA, and of 15ml of 37% HC1 in 100ml of dimethylsulfoxide (DMSO) was stirred at 55~60°C for 15hours. The reaction mixture was cooled at room temperature and then it was poured into 350ml of H2O and extracted with BuOH(350ml). The organic layer was washed with H2O(2 x 100ml) and concentrated at 50°C under reduced pressure to a small (-30ml) volume. On adding EtOAc (170ml) the precipitated solid was collected and dried at room temperature in vacuo overnight, yielding the title compounds.
Preparation of DMRA(Method B)
To a stirred solution of 5g (~3mmol) ofDMMAin 150ml ofa H2O-BuOH (2: 1) mixture, 1.5g ofNaBH4 was added portionwise at room temperature in 30 minutes. After stirring at room temperature for additional 4hours, the reaction mixture was cooled at 5°C and adjusted at pH 3.5 with glacial AcOH. After adding 300ml of a BuOH-H2O (3:1) mixture, the organic layer was separated, washed with 100 ml of H2O and concentrated at 35°C under reduced pressure to a small (-25ml) volume. On adding 150ml ofEtOAc the precipitated solid was collected and purified by reversedphase column chromatography as described above for RA, yielding 0.75 g of the title compound.
Preparation of MA-and RA-amides (General Procedure) To a stirred solution of 1mmol of MA, or RA, in 30ml of DMSO,1.15mmol of the appropriate amine and 600mg (~1.2mmol) ofPyBOP were added at room temperature. After stirring at 20~25°C for 3hours, 150ml ofEt2O was added and the precipitated solid was collected. Purification by reversed-phase column chromatography was performed with a linear gradient from 10 to 75% ofMeCN in 0.1 n AcOH. Fractions containing (HPLC) pure title compounds were pooled and worked-up as usual, yielding pure MA-or RA-amides.
Preparation of A-amides (General Procedure)
To a stirred suspension of 2.5mmol of the corresponding MA-amide in 60ml ofTHF, 10ml ofH2O and 20ml of I n NaOHwere added at room temperature. After 30minutes, the resulting solution was adjusted at pH 7 with 1n HC1, 150ml ofBuOHwas added and the resulting mixture was concentrated at 40°C underreduced pressure to a small (~20ml) volume. On adding Et2O (200 ml) the precipitated solid was collected and purified by reversed-phase column chromatography under the same conditions described above for the MA-and RA-amides, yielding pure title compounds.
Preparation of DMMA-A-1 AUG. 1995 To a stirred solution of 5g (~3mmol) ofDMMA in 50ml of DMSO, 0.5ml (~4mmol) of 3,3-dimethylamino-1-propylamine was added at room temperature followed by 1g of PyBOP. After 30minutes, EtOAc (250ml) was added and the precipitated solid was collected (5.1 g) and purified by reversed-phase column chromatography as described above for MA-and RAamides, yielding 2.5 g of the title compound.
Preparation of DMA-A-1
To a stirred solution of 1.7g (~lmmol) of DMMA-A-1in 35mT of a THF-H2O (6: 1) mixture, 5 ml of 1 N NaOHwas added at room temperature. After 1.0minutes, the reaction mixture was adjusted at pH 3 with In HC1 and extracted with BuOH (100ml). The organic layer was separated, washed with H2O(2 x 25 ml) and concentrated at 35°C under reduced pressure to a small (-5ml) volume. On adding EtOAc. (25ml) the precipitated solid was collected, washed with Et2O and dried at room temperature in vacuo overnight, yielding 0.75 g of the title compound.
Preparation of DMRA-A-1(Method B)
To a stirred solution of 1.7g (~lmmol) of DMMA-A-1in 70ml of a H2O-BuOH (2: 1) mixture, 0.5g of NaBH4was added at room temperature in 20 minutes. Stirring was continued for 2 hours, then the reaction mixture was cooled at 5°C and adjusted at pH 5 with glacial AcOH.The resulting solution was extracted with BuOH(150ml). The organic phase was separated, washed with H2O(50ml) and then it was concentrated at 40°C under reduced pressure to a small (~10ml) volume. On adding Et2O (100 ml) the precipitated solid was collected (1.1 g) and purified by reversed-phase chromatography under usual conditions, yielding 0.35 g of title compound.
Preparation of DMGA-A-1 A solution of1.7g (-1 mmol) ofDMRA-A-1 in 15ml of dry TFAwas stirred at room temperature for 1 hour.
The solvent wasevaporated at roomtemperature under reduced pressure, the oily residue was dissolved in 5ml of MeOHand then 20ml of EtOAc was added. The precipitated solid was collected and purified by reversed- Preparation of PyA-A-1 This compoundwas obtained, as the mono-acetate, from PyMA-A-1under the same conditions described above for the preparation of A-amides from MAamides.
